2025-04-08 18:25:26
Latest Post
Godrej Properties delivers its highest ever quarterly and full year bookings
Poonawalla Fincorp Launches Shopkeeper Loan Business
Revolt Motors Expands to 200 Dealerships, Targets 400 by FY26
Sobha Ltd - Real Estate Operational Update - Q4 FY 2024-25
Lemon Tree Hotels signs a new property in DarjeelingStock Report
Norris Medicines Ltd posts Rs. 2.23 crore loss in Q4FY22
Posted On : 2022-05-25 18:31:42( TIMEZONE : IST )
NORRIS MEDICINES LTD. has reported Standalone financial results for the period ended March 31, 2022.
Financial Results (Q4 FY2022) - QoQ Comparison
The company has reported total income of Rs. 0.8341 crores during the period ended March 31, 2022 as compared to Rs. 1.5212 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs. -2.2329 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. -0.1873 crores for the period ended December 31, 2021.
The company has reported EPS of Rs. -2.23 for the period ended March 31, 2022 as compared to Rs. -0.19 for the period ended December 31, 2021.
| Financials | Q4 FY2022 | Q3 FY2022 | % Change |
| Total Income | ₹ 0.8341 crs | ₹1.5212 crs |  -45.17% |
| Net Profit | ₹-2.2329 crs | ₹-0.1873 crs |  1,092.15% |
| EPS | ₹-2.23 | ₹-0.19 | 1,073.68% |
Financial Results (Q4 FY2022) - YoY Comparison
The company has reported total income of Rs. 0.8341 crores during the period ended March 31, 2022 as compared to Rs.2.5981 crores during the period ended March 31, 2021.
The company has posted net profit / (loss) of Rs.-2.2329 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.-3.1743 crores for the period ended March 31, 2021.
The company has reported EPS of Rs.-2.23 for the period ended March 31, 2022 as compared to Rs.-3.17 for the period ended March 31, 2021.
| Financials | Q4 FY2022 | Q4 FY2021 | % Change |
| Total Income | ₹ 0.8341 crs | ₹2.5981 crs | -67.90% |
| Net Profit | ₹-2.2329 crs | ₹-3.1743 crs |  29.66% |
| EPS | ₹-2.23 | ₹-3.17 | 29.65% |
Financial Results (Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.9.4642 crores during the Financial Year ended March 31, 2022 as compared to Rs.12.3007 crores during the Financial Year ended March 31, 2021.
The company has posted net profit / (loss) of Rs.-3.2635 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.-4.9619 crores for the Financial Year ended March 31, 2021.
The company has reported EPS of Rs.-3.26 for the Financial Year ended March 31, 2022 as compared to Rs.-4.96 for the Financial Year ended March 31, 2021.
| Financials | Year Ended FY2022 | Year Ended FY2021 | % Change |
| Total Income | ₹9.4642 crs | ₹12.3007 crs | -23.06% |
| Net Profit | ₹-3.2635 crs | ₹-4.9619 crs | 34.23% |
| EPS | ₹-3.26 | ₹-4.96 | 34.27% |
Shares of NORRIS MEDICINES LTD. was last trading in BSE at Rs. 19.05 as compared to the previous close of Rs. 20.05. The total number of shares traded during the day was 310 in over 6 trades.
The stock hit an intraday high of Rs. 19.05 and intraday low of 19.05. The net turnover during the day was Rs. 5905.00.
